- $506.68m
- $306.17m
- $228.39m
- 86
- 57
- 99
- 96
Annual balance sheet for CryoPort, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 93.3 | 629 | 523 | 457 | 262 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 31.4 | 39.4 | 43.9 | 42.1 | 45.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 147 | 694 | 604 | 535 | 342 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 44.1 | 69.7 | 90.5 | 118 | 136 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 552 | 1,113 | 1,039 | 958 | 703 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 35 | 42.6 | 40.9 | 45.6 | 64.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 170 | 471 | 483 | 469 | 302 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 383 | 642 | 556 | 489 | 402 |
| Total Liabilities & Shareholders' Equity | 552 | 1,113 | 1,039 | 958 | 703 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |